Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 69

1.

Subject specificity of the correlation between large-scale structural and functional connectivity.

Zimmermann J, Griffiths J, Schirner M, Ritter P, McIntosh AR.

Netw Neurosci. 2018 Oct 1;3(1):90-106. doi: 10.1162/netn_a_00055. eCollection 2019.

2.

Differentiation of Alzheimer's disease based on local and global parameters in personalized Virtual Brain models.

Zimmermann J, Perry A, Breakspear M, Schirner M, Sachdev P, Wen W, Kochan NA, Mapstone M, Ritter P, McIntosh AR, Solodkin A.

Neuroimage Clin. 2018 Apr 20;19:240-251. doi: 10.1016/j.nicl.2018.04.017. eCollection 2018.

3.

Modeling Brain Dynamics in Brain Tumor Patients Using the Virtual Brain.

Aerts H, Schirner M, Jeurissen B, Van Roost D, Achten E, Ritter P, Marinazzo D.

eNeuro. 2018 Jun 4;5(3). pii: ENEURO.0083-18.2018. doi: 10.1523/ENEURO.0083-18.2018. eCollection 2018 May-Jun.

4.

Inferring multi-scale neural mechanisms with brain network modelling.

Schirner M, McIntosh AR, Jirsa V, Deco G, Ritter P.

Elife. 2018 Jan 8;7. pii: e28927. doi: 10.7554/eLife.28927.

5.

How do parcellation size and short-range connectivity affect dynamics in large-scale brain network models?

Proix T, Spiegler A, Schirner M, Rothmeier S, Ritter P, Jirsa VK.

Neuroimage. 2016 Nov 15;142:135-149. doi: 10.1016/j.neuroimage.2016.06.016. Epub 2016 Jul 30.

PMID:
27480624
6.

Structural architecture supports functional organization in the human aging brain at a regionwise and network level.

Zimmermann J, Ritter P, Shen K, Rothmeier S, Schirner M, McIntosh AR.

Hum Brain Mapp. 2016 Jul;37(7):2645-61. doi: 10.1002/hbm.23200. Epub 2016 Apr 4.

PMID:
27041212
7.

TVB-EduPack-An Interactive Learning and Scripting Platform for The Virtual Brain.

Matzke H, Schirner M, Vollbrecht D, Rothmeier S, Llarena A, Rojas R, Triebkorn P, Domide L, Mersmann J, Solodkin A, Jirsa VK, McIntosh AR, Ritter P.

Front Neuroinform. 2015 Nov 25;9:27. doi: 10.3389/fninf.2015.00027. eCollection 2015.

8.

An automated pipeline for constructing personalized virtual brains from multimodal neuroimaging data.

Schirner M, Rothmeier S, Jirsa VK, McIntosh AR, Ritter P.

Neuroimage. 2015 Aug 15;117:343-57. doi: 10.1016/j.neuroimage.2015.03.055. Epub 2015 Mar 31.

9.

The virtual brain integrates computational modeling and multimodal neuroimaging.

Ritter P, Schirner M, McIntosh AR, Jirsa VK.

Brain Connect. 2013;3(2):121-45. doi: 10.1089/brain.2012.0120.

10.

Near-infrared fluorescence imaging of experimentally collagen-induced arthritis in rats using the nonspecific dye tetrasulfocyanine in comparison with gadolinium-based contrast-enhanced magnetic resonance imaging, histology, and clinical score.

Gemeinhardt I, Puls D, Gemeinhardt O, Taupitz M, Wagner S, Schnorr B, Licha K, Schirner M, Ebert B, Petzelt D, Macdonald R, Schnorr J.

J Biomed Opt. 2012 Oct;17(10):106008. doi: 10.1117/1.JBO.17.10.106008.

PMID:
23224007
11.

Inflammation assessment in patients with arthritis using a novel in vivo fluorescence optical imaging technology.

Werner SG, Langer HE, Ohrndorf S, Bahner M, Schott P, Schwenke C, Schirner M, Bastian H, Lind-Albrecht G, Kurtz B, Burmester GR, Backhaus M.

Ann Rheum Dis. 2012 Apr;71(4):504-10. doi: 10.1136/annrheumdis-2010-148288. Erratum in: Ann Rheum Dis. 2012 Oct;71(10):1756. Ann Rheum Dis. 2013 Jan;72(1):156.

12.

Fluorescence imaging with multifunctional polyglycerol sulfates: novel polymeric near-IR probes targeting inflammation.

Licha K, Welker P, Weinhart M, Wegner N, Kern S, Reichert S, Gemeinhardt I, Weissbach C, Ebert B, Haag R, Schirner M.

Bioconjug Chem. 2011 Dec 21;22(12):2453-60. doi: 10.1021/bc2002727. Epub 2011 Nov 17.

PMID:
22092336
13.

Detection of rheumatoid arthritis by evaluation of normalized variances of fluorescence time correlation functions.

Dziekan T, Weissbach C, Voigt J, Ebert B, Macdonald R, Bahner ML, Mahler M, Schirner M, Berliner M, Berliner B, Osel J, Osel I.

J Biomed Opt. 2011 Jul;16(7):076015. doi: 10.1117/1.3599958.

PMID:
21806276
14.

Dendritic polyglycerol sulfates as multivalent inhibitors of inflammation.

Dernedde J, Rausch A, Weinhart M, Enders S, Tauber R, Licha K, Schirner M, Zügel U, von Bonin A, Haag R.

Proc Natl Acad Sci U S A. 2010 Nov 16;107(46):19679-84. doi: 10.1073/pnas.1003103107. Epub 2010 Nov 1.

15.

New function for an old enzyme: NEP deficient mice develop late-onset obesity.

Becker M, Siems WE, Kluge R, Gembardt F, Schultheiss HP, Schirner M, Walther T.

PLoS One. 2010 Sep 16;5(9). pii: e12793. doi: 10.1371/journal.pone.0012793.

16.

Extra domain B fibronectin as a target for near-infrared fluorescence imaging of rheumatoid arthritis affected joints in vivo.

Vollmer S, Vater A, Licha K, Gemeinhardt I, Gemeinhardt O, Voigt J, Ebert B, Schnorr J, Taupitz M, Macdonald R, Schirner M.

Mol Imaging. 2009 Dec;8(6):330-40.

PMID:
20003891
17.

Near-infrared fluorescence imaging with fluorescently labeled albumin: a novel method for non-invasive optical imaging of blood-brain barrier impairment after focal cerebral ischemia in mice.

Klohs J, Steinbrink J, Bourayou R, Mueller S, Cordell R, Licha K, Schirner M, Dirnagl U, Lindauer U, Wunder A.

J Neurosci Methods. 2009 May 30;180(1):126-32. doi: 10.1016/j.jneumeth.2009.03.002. Epub 2009 Mar 20.

PMID:
19427539
18.

Optical agents.

Licha K, Schirner M, Henry G.

Handb Exp Pharmacol. 2008;(185 Pt 1):203-22. doi: 10.1007/978-3-540-72718-7_10. Review.

PMID:
18626805
19.

Inducible re-expression of p16 in an orthotopic mouse model of pancreatic cancer inhibits lymphangiogenesis and lymphatic metastasis.

Schulz P, Scholz A, Rexin A, Hauff P, Schirner M, Wiedenmann B, Detjen K.

Br J Cancer. 2008 Jul 8;99(1):110-7. doi: 10.1038/sj.bjc.6604457. Epub 2008 Jun 24.

20.

Differentiation of angiogenic burden in human cancer xenografts using a perfusion-type optical contrast agent (SIDAG).

Wall A, Persigehl T, Hauff P, Licha K, Schirner M, Müller S, von Wallbrunn A, Matuszewski L, Heindel W, Bremer C.

Breast Cancer Res. 2008;10(2):R23. doi: 10.1186/bcr1875. Epub 2008 Mar 10.

21.

Fab MOR03268 triggers absorption shift of a diagnostic dye via packaging in a solvent-shielded Fab dimer interface.

Hillig RC, Urlinger S, Fanghänel J, Brocks B, Haenel C, Stark Y, Sülzle D, Svergun DI, Baesler S, Malawski G, Moosmayer D, Menrad A, Schirner M, Licha K.

J Mol Biol. 2008 Mar 14;377(1):206-19. doi: 10.1016/j.jmb.2007.12.071. Epub 2008 Jan 5.

PMID:
18241888
22.

ED-B fibronectin (ED-B) can be targeted using a novel single chain antibody conjugate and is associated with macrophage accumulation in atherosclerotic lesions.

Dietrich T, Perlitz C, Licha K, Stawowy P, Atrott K, Tachezy M, Meyborg H, Stocker C, Gräfe M, Fleck E, Schirner M, Graf K.

Basic Res Cardiol. 2007 Jul;102(4):298-307. Epub 2007 Apr 30.

PMID:
17468934
23.

Crystallization and molecular-replacement solution of a diagnostic fluorescent dye in complex with a specific Fab fragment.

Hillig RC, Baesler S, Urlinger S, Stark Y, Bauer S, Badock V, Huber M, Bahr I, Schirner M, Licha K.

Acta Crystallogr Sect F Struct Biol Cryst Commun. 2007 Mar 1;63(Pt 3):217-23. Epub 2007 Feb 23.

24.

The in vitro stability of air-filled polybutylcyanoacrylate microparticles.

Olbrich C, Hauff P, Scholle F, Schmidt W, Bakowsky U, Briel A, Schirner M.

Biomaterials. 2006 Jul;27(19):3549-59. Epub 2006 Mar 14.

PMID:
16537092
25.

Assessment of unspecific near-infrared dyes in laser-induced fluorescence imaging of experimental arthritis.

Fischer T, Gemeinhardt I, Wagner S, Stieglitz DV, Schnorr J, Hermann KG, Ebert B, Petzelt D, Macdonald R, Licha K, Schirner M, Krenn V, Kamradt T, Taupitz M.

Acad Radiol. 2006 Jan;13(1):4-13.

PMID:
16399028
26.

In vivo molecular imaging of adhesion molecules in experimental autoimmune encephalomyelitis (EAE).

Linker RA, Reinhardt M, Bendszus M, Ladewig G, Briel A, Schirner M, Mäurer M, Hauff P.

J Autoimmun. 2005 Nov;25(3):199-205. Epub 2005 Oct 24.

PMID:
16249069
27.

Optical molecular imaging of lymph nodes using a targeted vascular contrast agent.

Licha K, Debus N, Emig-Vollmer S, Hofmann B, Hasbach M, Stibenz D, Sydow S, Schirner M, Ebert B, Petzelt D, Bührer C, Semmler W, Tauber R.

J Biomed Opt. 2005 Jul-Aug;10(4):41205.

PMID:
16178629
28.

Vascular endothelial growth factor-D induces lymphangiogenesis and lymphatic metastasis in models of ductal pancreatic cancer.

Von Marschall Z, Scholz A, Stacker SA, Achen MG, Jackson DG, Alves F, Schirner M, Haberey M, Thierauch KH, Wiedenmann B, Rosewicz S.

Int J Oncol. 2005 Sep;27(3):669-79.

PMID:
16077915
29.

Evaluation of gas-filled microparticles and sonoporation as gene delivery system: feasibility study in rodent tumor models.

Hauff P, Seemann S, Reszka R, Schultze-Mosgau M, Reinhardt M, Buzasi T, Plath T, Rosewicz S, Schirner M.

Radiology. 2005 Aug;236(2):572-8.

PMID:
16040915
30.

Comparison of two tricarbocyanine-based dyes for fluorescence optical imaging.

Perlitz C, Licha K, Scholle FD, Ebert B, Bahner M, Hauff P, Moesta KT, Schirner M.

J Fluoresc. 2005 May;15(3):443-54.

PMID:
15986163
31.

Ultrasound derived imaging and quantification of cell adhesion molecules in experimental autoimmune encephalomyelitis (EAE) by Sensitive Particle Acoustic Quantification (SPAQ).

Reinhardt M, Hauff P, Linker RA, Briel A, Gold R, Rieckmann P, Becker G, Toyka KV, Mäurer M, Schirner M.

Neuroimage. 2005 Aug 15;27(2):267-78.

PMID:
15905104
32.

Specific targeting of ultrasound contrast agent (USCA) for diagnostic application: an in vitro feasibility study based on SAW biosensor.

Joseph S, Gronewold TM, Schlensog MD, Olbrich C, Quandt E, Famulok M, Schirner M.

Biosens Bioelectron. 2005 Mar 15;20(9):1829-35.

PMID:
15681200
33.

Sensitive particle acoustic quantification (SPAQ): a new ultrasound-based approach for the quantification of ultrasound contrast media in high concentrations.

Reinhardt M, Hauff P, Briel A, Uhlendorf V, Linker RA, Mäurer M, Schirner M.

Invest Radiol. 2005 Jan;40(1):2-7.

PMID:
15597013
34.

A real-time in vitro assay for studying functional characteristics of target-specific ultrasound contrast agents.

Joseph S, Olbrich C, Kirsch J, Hasbach M, Briel A, Schirner M.

Pharm Res. 2004 Jun;21(6):920-6.

PMID:
15212154
35.

Molecular imaging of tumor angiogenesis.

Schirner M, Menrad A, Stephens A, Frenzel T, Hauff P, Licha K.

Ann N Y Acad Sci. 2004 Apr;1014:67-75. Review.

PMID:
15153421
36.

Molecular targeting of lymph nodes with L-selectin ligand-specific US contrast agent: a feasibility study in mice and dogs.

Hauff P, Reinhardt M, Briel A, Debus N, Schirner M.

Radiology. 2004 Jun;231(3):667-73. Epub 2004 Apr 29.

PMID:
15118116
37.

Differential regulation of in vivo angiogenesis by angiotensin II receptors.

Walther T, Menrad A, Orzechowski HD, Siemeister G, Paul M, Schirner M.

FASEB J. 2003 Nov;17(14):2061-7.

PMID:
14597675
38.

Activated signal transducer and activator of transcription 3 (STAT3) supports the malignant phenotype of human pancreatic cancer.

Scholz A, Heinze S, Detjen KM, Peters M, Welzel M, Hauff P, Schirner M, Wiedenmann B, Rosewicz S.

Gastroenterology. 2003 Sep;125(3):891-905.

PMID:
12949733
39.

Effects of interferon alpha on vascular endothelial growth factor gene transcription and tumor angiogenesis.

von Marschall Z, Scholz A, Cramer T, Schäfer G, Schirner M, Oberg K, Wiedenmann B, Höcker M, Rosewicz S.

J Natl Cancer Inst. 2003 Mar 19;95(6):437-48.

PMID:
12644537
40.

Concurrent induction of lymphangiogenesis, angiogenesis, and macrophage recruitment by vascular endothelial growth factor-C in melanoma.

Skobe M, Hamberg LM, Hawighorst T, Schirner M, Wolf GL, Alitalo K, Detmar M.

Am J Pathol. 2001 Sep;159(3):893-903.

41.

Antiangiogenic chemotherapeutic agents.

Schirner M.

Cancer Metastasis Rev. 2000;19(1-2):67-73. Review.

PMID:
11191065
42.

De novo expression of vascular endothelial growth factor in human pancreatic cancer: evidence for an autocrine mitogenic loop.

von Marschall Z, Cramer T, Höcker M, Burde R, Plath T, Schirner M, Heidenreich R, Breier G, Riecken EO, Wiedenmann B, Rosewicz S.

Gastroenterology. 2000 Nov;119(5):1358-72.

PMID:
11054395
43.

A novel function for the tumor suppressor p16(INK4a): induction of anoikis via upregulation of the alpha(5)beta(1) fibronectin receptor.

Plath T, Detjen K, Welzel M, von Marschall Z, Murphy D, Schirner M, Wiedenmann B, Rosewicz S.

J Cell Biol. 2000 Sep 18;150(6):1467-78.

44.

PTK787/ZK 222584, a novel and potent inhibitor of vascular endothelial growth factor receptor tyrosine kinases, impairs vascular endothelial growth factor-induced responses and tumor growth after oral administration.

Wood JM, Bold G, Buchdunger E, Cozens R, Ferrari S, Frei J, Hofmann F, Mestan J, Mett H, O'Reilly T, Persohn E, Rösel J, Schnell C, Stover D, Theuer A, Towbin H, Wenger F, Woods-Cook K, Menrad A, Siemeister G, Schirner M, Thierauch KH, Schneider MR, Drevs J, Martiny-Baron G, Totzke F.

Cancer Res. 2000 Apr 15;60(8):2178-89.

45.
46.

Integrin alpha5beta1: a potent inhibitor of experimental lung metastasis.

Schirner M, Herzberg F, Schmidt R, Streit M, Schöning M, Hummel M, Kaufmann C, Thiel E, Kreuser ED.

Clin Exp Metastasis. 1998 Jul;16(5):427-35.

PMID:
10091938
47.

Vascular endothelial growth factor (VEGF) receptor II-derived peptides inhibit VEGF.

Piossek C, Schneider-Mergener J, Schirner M, Vakalopoulou E, Germeroth L, Thierauch KH.

J Biol Chem. 1999 Feb 26;274(9):5612-9.

48.

Tumor metastasis inhibition with the prostacyclin analogue cicaprost depends on discontinuous plasma peak levels.

Schirner M, Kraus C, Lichtner RB, Schneider MR, Hildebrand M.

Prostaglandins Leukot Essent Fatty Acids. 1998 Apr;58(4):311-7.

PMID:
9654405
49.
50.

An antagonistic vascular endothelial growth factor (VEGF) variant inhibits VEGF-stimulated receptor autophosphorylation and proliferation of human endothelial cells.

Siemeister G, Schirner M, Reusch P, Barleon B, Marmé D, Martiny-Baron G.

Proc Natl Acad Sci U S A. 1998 Apr 14;95(8):4625-9.

Supplemental Content

Loading ...
Support Center